Interstitial Lung Disease Clinical Trials in Kansas City, Kansas

6 studies are recruiting for interstitial lung disease in Kansas City, Kansas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

   This is a prospective, real world, multicenter, registry of patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD) and interstitial lung disease (ILD).

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Kansas Medical Center, Kansas City, Kansas

   Locations

   71 in total

   Run by

   United Therapeutics

   See if you can join NCT06388421 on ClinicalTrials.gov

2. Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

   The primary objective of this study is to evaluate the effect of 24-weeks of once daily treatment with TPIP versus placebo on exercise capacity in adults with PH-ILD.

   Stage

   Phase 3

   Ages

   18 and older

   Site

   USA002, Kansas City, Kansas

   Locations

   145 in total

   Run by

   Insmed Incorporated

   See if you can join NCT07179380 on ClinicalTrials.gov

3. Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

   Study RIN-PF-305 is designed to evaluate the safety and efficacy of inhaled treprostinil in subjects with progressive pulmonary fibrosis (PPF) over a 52-week period.

   Stage

   Phase 3

   Ages

   18 and older

   Site

   University of Kansas Medical Center, Kansas City, Kansas

   Locations

   165 in total

   Run by

   United Therapeutics

   See if you can join NCT05943535 on ClinicalTrials.gov

4. Interstitial Lung Disease Research Unit Biobank

   Establish a interstitial lung disease (ILD) registry and biorepository to lead towards a further understanding of the disease.

   Stage

   Not phased

   Ages

   18 and older

   Site

   The University of Kansas Medical Center, Kansas City, Kansas

   Run by

   University of Kansas Medical Center

   See if you can join NCT05392881 on ClinicalTrials.gov

5. Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease

   The purpose of this study is to develop and evaluate the usefulness of hyperpolarized (HP) 129Xe gas MRI for regional assessment of pulmonary function.

   Stage

   Phase 1

   Ages

   3 and older

   Site

   University of Kansas Medical Center, Kansas City, Kansas

   Run by

   Mario Castro, MD, MPH

   See if you can join NCT04624490 on ClinicalTrials.gov

6. Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

   A study to identify patients with Rheumatoid Arthritis - Associated Interstitial Lung Disease (RA-ILD) that are at the highest risk for progression. The goal of the investigators is to recruit a group of patients with RA-ILD and collect information to help us understand more about disease progressi…

   Stage

   Not phased

   Ages

   18 to 90

   Site

   University of Kansas, Kansas City, Kansas

   Locations

   4 in total

   Run by

   University of Colorado, Denver

   See if you can join NCT06397677 on ClinicalTrials.gov